Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates – Novavax (NASDAQ:NVAX)
[ad_1] Novavax Inc NVAX has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates. The dose-confirming trial will evaluate the safety and effectiveness (immunogenicity)…
Aussie finishes strong in 2022
[ad_1] The Australian dollar has been rising since last Friday and is in positive territory today. In the European session, AUD/USD is trading at 0.6801, up 0.37%. The final week…
U.S. dollar widely unchanged as greenback is on track for best year since 2015 By Investing.com
[ad_1] © Reuters By Scott Kanowsky Investing.com — The U.S. dollar was broadly unchanged in limited European trading on Friday, as it stayed on track for its biggest increase in seven…
Surrenders Gains as 1.0700 Resistance Holds Firm
[ad_1] KEY POINTS: Recommended by Zain Vawda Get Your Free EUR Forecast READ MORE: EUR/USD Outlook: Doji Candlestick Highlights Messy Price Action EUR/USD OUTLOOK EUR/USD enjoyed its best day of…
Swiss franc touches 9-month high
[ad_1] The Swiss franc is steady on Friday. In the European session, USD/CHF is almost trading at 0.9240, up 0.08%. On Thursday, USD/CHF dropped by 0.6% and hit a low…